Cargando…

Molecular profiles of response to neoadjuvant chemoradiotherapy in oesophageal cancers to develop personalized treatment strategies

Identification of molecular predictive markers of response to neoadjuvant chemoradiation could aid clinical decision‐making in patients with localized oesophageal cancer. Therefore, we subjected pretreatment biopsies of 75 adenocarcinoma (OAC) and 16 squamous cell carcinoma (OSCC) patients to target...

Descripción completa

Detalles Bibliográficos
Autores principales:	de Klerk, Leonie K., Goedegebuure, Ruben S. A., van Grieken, Nicole C. T., van Sandick, Johanna W., Cats, Annemieke, Stiekema, Jurrien, van der Kaaij, Rosa T., Farina Sarasqueta, Arantza, van Engeland, Manon, Jacobs, Maarten A. J. M., van Wanrooij, Roy L. J., van der Peet, Donald L., Thorner, Aaron R., Verheul, Henk M. W., Thijssen, Victor L. J. L., Bass, Adam J., Derks, Sarah
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8024738/ https://www.ncbi.nlm.nih.gov/pubmed/33506581 http://dx.doi.org/10.1002/1878-0261.12907

Ejemplares similares

Pre-treatment tumor-infiltrating T cells influence response to neoadjuvant chemoradiotherapy in esophageal adenocarcinoma
por: Goedegebuure, R.S.A., et al.
Publicado: (2021)

Combining Radiotherapy With Anti-angiogenic Therapy and Immunotherapy; A Therapeutic Triad for Cancer?
por: Goedegebuure, Ruben S. A., et al.
Publicado: (2019)

Towards Personalization in the Curative Treatment of Gastric Cancer
por: Slagter, Astrid E., et al.
Publicado: (2020)

Treatment of Peritoneal Dissemination in Stomach Cancer Patients With Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC): Rationale and Design of the PERISCOPE Study
por: van der Kaaij, Rosa T, et al.
Publicado: (2017)

Neo-adjuvant chemotherapy followed by surgery and chemotherapy or by surgery and chemoradiotherapy for patients with resectable gastric cancer (CRITICS)
por: Dikken, Johan L, et al.
Publicado: (2011)

International benchmarking in oesophageal and gastric cancer surgery
por: Busweiler, L. A. D., et al.
Publicado: (2018)

Interferon- and STING-independent induction of type I interferon stimulated genes during fractionated irradiation
por: Goedegebuure, Ruben S. A., et al.
Publicado: (2021)

Supervised exercise after oesophageal cancer surgery: the PERFECT multicentre randomized clinical trial
por: van Vulpen, J K, et al.
Publicado: (2021)

Venous thromboembolism during preoperative chemotherapy in the CRITICS gastric cancer trial
por: Slagter, Astrid E., et al.
Publicado: (2020)

Risk Factors for Metachronous Isolated Peritoneal Metastasis after Preoperative Chemotherapy and Potentially Curative Gastric Cancer Resection: Results from the CRITICS Trial
por: Caspers, Irene A., et al.
Publicado: (2021)

Pattern of recurrence in patients with a pathologically complete response after neoadjuvant chemoradiotherapy and surgery for oesophageal cancer
por: de Jongh, M, et al.
Publicado: (2021)

CRITICS-II: a multicentre randomised phase II trial of neo-adjuvant chemotherapy followed by surgery versus neo-adjuvant chemotherapy and subsequent chemoradiotherapy followed by surgery versus neo-adjuvant chemoradiotherapy followed by surgery in resectable gastric cancer
por: Slagter, Astrid E., et al.
Publicado: (2018)

Neoadjuvant chemoradiotherapy plus surgery versus active surveillance for oesophageal cancer: a stepped-wedge cluster randomised trial
por: Noordman, Bo Jan, et al.
Publicado: (2018)

Active surveillance of oesophageal cancer after response to neoadjuvant chemoradiotherapy: dysphagia is uncommon
por: Valkema, Maria J, et al.
Publicado: (2023)

Benchmarking of a Simple Scintigraphic Test for Gastro-oesophageal Reflux Disease That Assesses Oesophageal Disease and Its Pulmonary Complications
por: Burton, Leticia, et al.
Publicado: (2018)

EUS-guided gastroenterostomy in patients with ascites: What lies beneath?
por: Bronswijk, Michiel, et al.
Publicado: (2022)

EUS-guided choledochoduodenostomy and duodenal stenosis: A marriage doomed to fail?
por: Bronswijk, Michiel, et al.
Publicado: (2022)

Cisplatin and etoposide in oesophageal cancer: a phase II study. Rotterdam Oesophageal Tumour Study Group.
por: Kok, T. C., et al.
Publicado: (1996)

Transhiatal vs extended transthoracic resection in oesophageal carcinoma: patients' utilities and treatment preferences
por: de Boer, A G E M, et al.
Publicado: (2002)

Triplet Chemotherapy with Cisplatin versus Oxaliplatin in the CRITICS Trial: Treatment Compliance, Toxicity, Outcomes and Quality of Life in Patients with Resectable Gastric Cancer
por: Slagter, Astrid E., et al.
Publicado: (2022)

Response to neoadjuvant chemotherapy and survival in molecular subtypes of resectable gastric cancer: a post hoc analysis of the D1/D2 and CRITICS trials
por: Biesma, Hedde D., et al.
Publicado: (2022)

First-line treatment with oxaliplatin and capecitabine in patients with advanced or metastatic oesophageal cancer: a phase II study
por: van Meerten, E, et al.
Publicado: (2007)

Updated protocol of the SANO trial: a stepped-wedge cluster randomised trial comparing surgery with active surveillance after neoadjuvant chemoradiotherapy for oesophageal cancer
por: Eyck, Ben M., et al.
Publicado: (2021)

A prospective, randomized placebo‐controlled clinical trial on the effects of a fluoride rinse on white spot lesion development and bleeding in orthodontic patients
por: van der Kaaij, Nicoline C. W., et al.
Publicado: (2015)

A rare case of oesophageal rupture: Boerhaave's syndrome
por: van der Weg, Gerben, et al.
Publicado: (2014)

Long-Term Survival After Complications Following Major Abdominal Surgery
por: Straatman, Jennifer, et al.
Publicado: (2016)

Minimally Invasive Versus Open Total Gastrectomy for Gastric Cancer: A Systematic Review and Meta-analysis of Short-Term Outcomes and Completeness of Resection: Surgical Techniques in Gastric Cancer
por: Straatman, Jennifer, et al.
Publicado: (2015)

Prevention of post-ERCP pancreatitis: NSAID or pancreatic stent or both?
por: van Wanrooij, R. L. J., et al.
Publicado: (2019)

Phase II study of bi-weekly administration of paclitaxel and cisplatin in patients with advanced oesophageal cancer
por: Polee, M B, et al.
Publicado: (2002)

Cone-Beam CT-based position verification for oesophageal cancer: Evaluation of registration methods and anatomical changes during radiotherapy
por: van Nunen, A., et al.
Publicado: (2017)

Submucosal Epinephrine Injection Before Endoscopic Papillectomy: Less is More?
por: van Wanrooij, Roy L.J., et al.
Publicado: (2021)

Oesophageal adenocarcinoma: In the era of extended lymphadenectomy, is the value of neoadjuvant therapy being attenuated?
por: Park, Jin-Soo, et al.
Publicado: (2021)

Outcome of Referrals for Non-Responsive Celiac Disease in a Tertiary Center: Low Incidence of Refractory Celiac Disease in the Netherlands
por: van Wanrooij, R L J, et al.
Publicado: (2017)

Prognostic value of tumor markers and ctDNA in patients with resectable gastric cancer receiving perioperative treatment: results from the CRITICS trial
por: Slagter, Astrid E., et al.
Publicado: (2021)

Epidemiological changes in oesophageal cancer at National Hospital, Bloemfontein: 1995, 2000 and 2005
por: van der Merwe, Tian, et al.
Publicado: (2010)

White blood cell and cell-free DNA analyses for detection of residual disease in gastric cancer
por: Leal, Alessandro, et al.
Publicado: (2020)

Prognostic factors for survival in patients with advanced oesophageal cancer treated with cisplatin-based combination chemotherapy
por: Polee, M B, et al.
Publicado: (2003)

Detection of lymph node metastases with ultrasmall superparamagnetic iron oxide (USPIO)-enhanced magnetic resonance imaging in oesophageal cancer: a feasibility study
por: Pultrum, B.B., et al.
Publicado: (2009)

PD-1 The impact of COVID-19 on diagnosis, stage and treatment of esophageal and gastric cancer
por: Bakx, J., et al.
Publicado: (2022)

Kinase Inhibitor Treatment of Patients with Advanced Cancer Results in High Tumor Drug Concentrations and in Specific Alterations of the Tumor Phosphoproteome
por: Labots, Mariette, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_9ir00pjcs3gmk0gki2o2rph6er